Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Camille Bedrosian, MD
Alexion Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Melbourne, Australia
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Paris, France
- Universitatsklinikum Essen
Essen, Germany
- Institut Fur Klinische Transfusionmedizin Und Immungenetick
Ulm, Germany
- Facility name not stated
Dublin, Ireland
- Azienda Ospediliera Universitatia Careggi
Florence, Italy
- Universita Degli Studi Di Napoli
Naples, Italy
- Facility name not stated
Nijmegen, Netherlands
- Facility name not stated
Basel, Switzerland
- Facility name not stated
London, United Kingdom
- University Park Hematology Oncology
Englewood, Colorado, United States
- Cleveland Clinic Florida
Weston, Florida, United States
- Maine Cancer Center of Medicine
Scarborough, Maine, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2012
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 18 Oct 2017
- Registered enrollment
- 75
- Registry id
- NCT01412047
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.